Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-24-000829
Filing Date
2024-11-12
Accepted
2024-11-12 13:33:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 UnitedStates_13G__ActiniumPh.txt SC 13G/A 5004
  Complete submission text file 0000932471-24-000829.txt   6640
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82467 | Film No.: 241446583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)